The most important macro catalyst of the quarter arrived on July 2, when the US Bureau of Labor Statistics reported that the economy added just 57,000 jobs in June—well below the 110,000 consensus forecast BM. The prior two months were revised down by a combined 74,000 jobs BC. The miss sharply reduced expectations of a Federal Reserve rate hike, with CME FedWatch data showing a 75.6% probability the Fed would hold rates at its July meeting P.
On the other side of the Atlantic, eurozone inflation provided another tailwind. Eurostat flash estimates showed annual inflation in the eurozone fell to 2.8% in June, down from 3.2% in May, helped by oil prices dropping to pre-war levels EI. Core inflation eased to 2.4%, also missing forecasts T. The combination of a cooling US labor market and falling eurozone inflation pushed European equities higher, as global rate-hike fears receded.
Contrary to the market narrative of rate cuts, the European Central Bank actually raised rates during the quarter. On June 11, 2026, the ECB increased its three key interest rates by 25 basis points—the first hike since 2023—bringing the deposit facility rate to 2.25% E. The ECB cited "sticky services inflation and a resilient economy" as reasons for the move EE. This decision ran counter to a December 2025 Reuters poll where all 96 economists surveyed expected rates to stay on hold through the end of 2026 R. The dovish macro catalyst for equities, therefore, came from the US side, not from the ECB.
Technology shares were a key driver of the STOXX 600's quarterly gain. Reuters reported that on June 30, "technology stocks led the charge with a 2.5% gain" and clocked their biggest quarterly increase since 2001 M. The sector was supported by renewed AI optimism following a previous sell-off F.
The rally broadened beyond tech as the quarter progressed. On July 3, gains in cyclical stocks, including industrial giant Siemens, pushed the STOXX 600 to its record R. February's records had also been supported by advances in the banking and defense sectors R. On February 18, the STOXX 600 surged 0.8% to an all-time high of 626.36 as defense and banking stocks gained R.
Perhaps the single most dramatic catalyst was the June 15 preliminary agreement between the United States and Iran. Reuters reported that the STOXX 600 hit a record high "following a preliminary agreement between the United States and Iran to conclude their conflict and reopen the Strait of Hormuz" R. The de-escalation removed a major geopolitical risk and alleviated concerns about energy supply disruptions, which had been pushing oil prices higher.
One of the largest M&A stories of the quarter was the protracted takeover battle for British budget airline easyJet. US investment firm Castlelake first disclosed its interest in easyJet in May 2026 G. Over the following weeks, easyJet's board rejected four separate bids, including a £4.7 billion offer at 625p per share and a £4.93 billion offer at £6.50 per share RTT.
On July 5, Castlelake's fifth and sweetened offer of £6.90 per share—valuing the carrier at £5.5 billion ($7.34 billion)—finally broke the deadlock, and easyJet's board agreed in principle to the takeover RFW. The offer represented a 73% premium to easyJet's closing price on May 29, when Castlelake first disclosed its interest W.
EasyJet shares surged 10% on July 6, hitting four-year highs RR. However, analysts flagged potential regulatory hurdles, including EU ownership rules that require airlines to be majority-owned by EU or European Economic Area nationals, as well as the need for shareholder approval RR. Notably, easyJet's shares held at £6.14 on the day—still well below the £6.90 bid price—reflecting some investor skepticism about the deal's completion R.
Claims that JPMorgan and Barclays raised their STOXX 600 targets during the quarter could not be independently verified within the scope of this fact-check. Similarly, specific moves such as Sodexo raising its revenue forecast, Bayer consolidating its Roundup business, SKF forming a joint venture, and Nordea beating profit estimates were mentioned in the initial research request but were not confirmed by sourced evidence in this search run. These are noted as unverified.